Navigation Links
Notre Dame researchers develop system that uses a big data approach to personalized healthcare
Date:7/25/2013

University of Notre Dame researchers have developed a computer-aided method that uses electronic medical records to offer the promise of rapid advances toward personalized health care, disease management and wellness.

Notre Dame computer science professor Nitesh V. Chawla and his doctoral student, Darcy A. Davis, developed the system called Collaborative Assessment and Recommendation Engine (CARE) for personalized disease risk predictions and wellbeing.

"The potential for 'personalizing' health care from a disease prevention, disease management and therapeutics perspective is increasing," Chawla said. "Health care informatics and advanced analytics, or data science, may contribute to this shift from population-based evidence for health care decision-making to the fusion of population and individual based evidence in health care. The key question is: how to leverage health population data to drive patient-centered health care?"

At the heart of CARE is a novel collaborative filtering method that captures patient similarities and produces personalized disease risk profiles for individuals. Using what is known as Big Data science, the system generates predictions focused on other diseases that are based on Big Data from similar patients.

"In its most conservative use, the CARE rankings can provide reminders for conditions that busy doctors may have overlooked," Chawla said. "Utilized to its full potential, CARE can be used to explore broader disease histories, suggest previously unconsidered concerns, and facilitate discussion about early testing and prevention, as well as wellness strategies that may ring a more familiar bell with an individual and are essentially doable.

"We believe that our work can lead to reduced re-admission rates, improved quality of care ratings and can demonstrate meaningful use, impact personal and population health, and push forward the discussion and impact on the patient-centered paradigm."

Chawla points out that the core premise of CARE is centered on patient empowerment and patient engagement.

"Imagine visiting your physician's office with a list of concerns and questions," he said. "What if you could walk out of the office with a personalized assessment of your health, along with a list of personalized and important lifestyle change recommendations based on your predicted health risks? What if your physician was afforded a limitless experience to gauge the impact of your disease toward developing other diseases in the future? What if you could find out that there are other patients similar to you not only with respect to major symptoms, but also with respect to rare issues that have puzzled your doctor? What if you could have the experience of others at your fingertips and fathom the lifestyle changes warranted for mitigating diseases?"

Chawla believes the timing is right for CARE given changes in health care, reimbursement, reform, meaningful use of electronic health care data and a mandate for patient-centered outcomes.

"The industry is seeing a move toward health and wellbeing and how that can be personalized to an individual," he said. "There is an increased focus on preventative care, wellbeing and reducing re-admission rates in the hospital. This system can help bend the cost curve."

CARE has been awarded a U.S. patent.


'/>"/>

Contact: Nitesh Chawla
nchawla@nd.edu
574-631-1090
University of Notre Dame
Source:Eurekalert

Related biology news :

1. Notre Dame study finds Asian carp DNA not widespread in the Great Lakes
2. Notre Dame researcher is studying role small dams play in pollution control
3. Notre Dame researchers are using new technologies to combat invasive species
4. Notre Dame research may have important implications for combating diabetes
5. Cargill expands support of Notre Dame Haiti Program
6. Notre Dame research reveals migrating Great Lakes salmon carry contaminants upstream
7. Notre Dame research could improve sustainability and cost effectiveness of wastewater treatment
8. Notre Dame research could provide new insights into tuberculosis and other diseases
9. Notre Dame researcher is shedding light on how jaws evolve
10. Notre Dame establishes professorships in adult stem cell research
11. Notre Dame researchers using novel method to combat malaria drug resistance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... DUBLIN , April 15, 2016 ... of the,  "Global Gait Biometrics Market 2016-2020,"  report ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait ... CAGR of 13.98% during the period 2016-2020. ... movement angles, which can be used to compute ...
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting Medicaid ... setting a new clinical standard in telehealth thanks to ... leveraging the higi platform, IMPOWER patients can routinely track ... and body mass index, and, when they opt in, ... convenient visit to a local retail location at no ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge ... envision new ways to harness living systems and biotechnology, ... Art (MoMA) in New York City ... 130 participating students, showcased projects at MoMA,s Celeste Bartos ... Paola Antonelli , MoMA,s senior curator of architecture and ...
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
(Date:6/23/2016)... , June 23, 2016 On ... session at 4,833.32, down 0.22%; the Dow Jones Industrial Average ... 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez ... Inc. (NASDAQ: BIND ). Learn more about these ...
(Date:6/23/2016)... , June 22, 2016  Amgen (NASDAQ: ... the QB3@953 life sciences incubator to accelerate ... The shared laboratory space at QB3@953 was created to ... key obstacle for many early stage organizations - access ... the sponsorship, Amgen launched two "Amgen Golden Ticket" awards, ...
Breaking Biology Technology: